Published in Lancet Infect Dis on January 01, 2010
Asymptomatic Bacteriuria in Early Kidney Transplantation Follow up | NCT04333602
Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc (2011) 1.89
Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother (2010) 1.74
Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother (2012) 1.64
Dissemination of the fosfomycin resistance gene fosA3 with CTX-M β-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother (2012) 1.54
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infect Dis (2015) 1.34
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother (2014) 1.19
In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development. Antimicrob Agents Chemother (2011) 1.16
Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria. Microbiol Insights (2016) 1.13
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario? Antimicrob Agents Chemother (2011) 1.04
Divergence of chemical function in the alkaline phosphatase superfamily: structure and mechanism of the P-C bond cleaving enzyme phosphonoacetate hydrolase. Biochemistry (2011) 1.03
Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer? Urol Ann (2015) 1.03
Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient. Ann Saudi Med (2010) 1.00
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. World J Urol (2013) 0.98
F33: A-: B-, IncHI2/ST3, and IncI1/ST71 plasmids drive the dissemination of fosA3 and bla CTX-M-55/-14/-65 in Escherichia coli from chickens in China. Front Microbiol (2014) 0.95
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis (2011) 0.93
Rapid detection of extended-spectrum-β-lactamase-producing enterobacteriaceae from urine samples by use of the ESBL NDP test. J Clin Microbiol (2014) 0.90
Fosfomycin. Clin Microbiol Rev (2016) 0.89
The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock. Virulence (2013) 0.89
Clinical management of infections caused by multidrug-resistant Enterobacteriaceae. Ther Adv Infect Dis (2013) 0.88
Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis. Antimicrob Agents Chemother (2015) 0.87
Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan. Pak J Med Sci (2013) 0.87
Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake. J Bacteriol (2013) 0.86
Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance. Antimicrob Agents Chemother (2015) 0.86
Bacterial prostatitis. World J Urol (2013) 0.86
Fosfomycin: Resurgence of an old companion. J Infect Chemother (2016) 0.86
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance. Antibiotics (Basel) (2013) 0.85
Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study. PLoS One (2014) 0.85
First report of a clinical, multidrug-resistant Enterobacteriaceae isolate coharboring fosfomycin resistance gene fosA3 and carbapenemase gene blaKPC-2 on the same transposon, Tn1721. Antimicrob Agents Chemother (2014) 0.85
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model. Antimicrob Agents Chemother (2015) 0.85
Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China. PLoS One (2015) 0.85
Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan. PLoS One (2015) 0.85
Discovery of the antibiotic phosacetamycin via a new mass spectrometry-based method for phosphonic acid detection. ACS Chem Biol (2013) 0.84
New Delhi Metallo-beta lactamase-1 containing enterobacteriaceae: origin, diagnosis, treatment and public health concern. Pan Afr Med J (2012) 0.83
Fosfomycin: An Alternative Therapy for the Treatment of UTI Amidst Escalating Antimicrobial Resistance. J Clin Diagn Res (2015) 0.82
Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis (2016) 0.82
Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens. Eur J Clin Microbiol Infect Dis (2012) 0.81
How to treat VAP due to MDR pathogens in ICU patients. BMC Infect Dis (2014) 0.81
Fosfomycin tromethamine. Antibiotic of choice in the female patient: A multicenter study. Cent European J Urol (2015) 0.80
Molecular Characterization of Escherichia coli Strains Isolated from Retail Meat That Harbor blaCTX-M and fosA3 Genes. Antimicrob Agents Chemother (2016) 0.80
Clinical Efficacy of Ertapenem for Recurrent Cystitis Caused by Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli in Female Outpatients. Korean J Urol (2014) 0.80
Identification of a second two-component signal transduction system that controls fosfomycin tolerance and glycerol-3-phosphate uptake. J Bacteriol (2014) 0.79
Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. World J Urol (2016) 0.78
Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database. Infect Dis Ther (2015) 0.78
Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa. Antimicrob Agents Chemother (2013) 0.78
In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece. Antimicrob Agents Chemother (2012) 0.78
The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study. Can Urol Assoc J (2015) 0.77
Extended-spectrum-beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function. PLoS One (2014) 0.77
Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model. Antimicrob Agents Chemother (2016) 0.75
Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates. Biomed Res Int (2017) 0.75
Uncomplicated Urinary Tract Infections and Antibiotic Resistance-Epidemiological and Mechanistic Aspects. Antibiotics (Basel) (2014) 0.75
Comparative Evaluation of Fosfomycin Activity with other Antimicrobial Agents against E.coli Isolates from Urinary Tract Infections. J Clin Diagn Res (2017) 0.75
Determination of susceptibility to fosfomycin and tigecycline of Enterobacteriaceae, particularly Escherichia coli isolates, producing extended-spectrum β-lactamases from multiple regional Canadian hospitals. Can J Infect Dis Med Microbiol (2013) 0.75
Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae. Exp Ther Med (2017) 0.75
Favorable outcome in cerebral abscesses caused by Citrobacter koseri in a newborn infant. IDCases (2014) 0.75
Validation of Cefazolin as Initial Antibiotic for First Upper Urinary Tract Infection in Children. Glob Pediatr Health (2016) 0.75
Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogens. Indian J Urol (2017) 0.75
Complete Sequence of a F33:A-:B- Conjugative Plasmid Carrying the oqxAB, fosA3, and blaCTX-M-55 Elements from a Foodborne Escherichia coli Strain. Front Microbiol (2016) 0.75
Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001-2015. Sci Rep (2016) 0.75
Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains. Iran J Microbiol (2016) 0.75
Fosfomycin induced structural change in fosfomycin resistance kinases FomA: molecular dynamics and molecular docking studies. J Mol Model (2014) 0.75
A Study of 24 Patients with Colistin-Resistant Gram-negative Isolates in a Tertiary Care Hospital in South India. Indian J Crit Care Med (2017) 0.75
RpoS-independent evolution reveals the importance of attenuated cAMP/CRP regulation in high hydrostatic pressure resistance acquisition in E. coli. Sci Rep (2017) 0.75
First Detection of a Fosfomycin Resistance Gene fosA7 in Salmonella enterica serovar Heidelberg Isolated from Broiler Chickens. Antimicrob Agents Chemother (2017) 0.75
Fosfomycin for the treatment of drug-resistant urinary tract infections: potential of an old drug not explored fully. Int Urol Nephrol (2017) 0.75
Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance. Eur J Clin Microbiol Infect Dis (2012) 0.75
Characterization of Extended-Spectrum β-Lactamase Genes of Shigella flexneri Isolates With Fosfomycin Resistance From Patients in China. Ann Lab Med (2017) 0.75
Pharmacodynamic evaluation of fosfomycin against E. coli and Klebsiella spp. from urinary tract infections and the influence of pH on fosfomycin activities. Antimicrob Agents Chemother (2017) 0.75
Obesity and infection. Lancet Infect Dis (2006) 2.94
Comparison of SCImago journal rank indicator with journal impact factor. FASEB J (2008) 2.77
The top-ten in journal impact factor manipulation. Arch Immunol Ther Exp (Warsz) (2008) 2.32
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis (2014) 2.29
Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet (2009) 2.26
Fosfomycin: use beyond urinary tract and gastrointestinal infections. Clin Infect Dis (2008) 2.08
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother (2008) 1.98
Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol (2011) 1.97
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis (2008) 1.91
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents (2009) 1.88
Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother (2008) 1.73
Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med (2008) 1.69
The effect of psychosocial factors on breast cancer outcome: a systematic review. Breast Cancer Res (2007) 1.65
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care (2005) 1.58
Prevalence of hepatitis B, hepatitis C, and HIV infections among patients in a psychiatric hospital in Greece. Psychiatr Serv (2009) 1.54
Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care (2007) 1.52
A bibliometric analysis by geographic area of published research in several biomedical fields, 1995-2003. CMAJ (2006) 1.46
World Wide Web resources on antimicrobial resistance. Clin Infect Dis (2006) 1.46
Microbiologically documented nosocomial infections after coronary artery bypass surgery without cardiopulmonary bypass. J Thorac Cardiovasc Surg (2006) 1.45
Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials. Mayo Clin Proc (2008) 1.42
The impact of article length on the number of future citations: a bibliometric analysis of general medicine journals. PLoS One (2013) 1.35
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents (2009) 1.35
Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol (2009) 1.34
Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother (2012) 1.29
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents (2009) 1.23
Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med (2011) 1.20
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin Investig Drugs (2009) 1.19
Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents (2009) 1.19
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents (2010) 1.18
MRSA in Africa: filling the global map of antimicrobial resistance. PLoS One (2013) 1.15
Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review. Eur J Pharmacol (2006) 1.12
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One (2012) 1.10
Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs (2009) 1.07
Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis. Drugs (2008) 1.01
Comparison of antibiotics with placebo for treatment of acute sinusitis: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2008) 1.01
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother (2010) 0.99
Regression of skin lesions of Kyrle's disease with clindamycin: implications for an infectious component in the etiology of the disease. J Infect (2005) 0.95
Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis. Pediatr Infect Dis J (2009) 0.94
Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials. J Antimicrob Chemother (2009) 0.94
Comparison of utility of blood cultures from intravascular catheters and peripheral veins: a systematic review and decision analysis. J Med Microbiol (2008) 0.93
Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Expert Rev Anti Infect Ther (2013) 0.92
Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci (2013) 0.91
Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials. Future Microbiol (2010) 0.91
Patients' perception of quality of pre-operative informed consent in athens, Greece: a pilot study. PLoS One (2009) 0.90
Impact of vancomycin minimum inhibitory concentration on clinical outcomes of patients with vancomycin-susceptible Staphylococcus aureus infections: a meta-analysis and meta-regression. Int J Antimicrob Agents (2012) 0.90
Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic review. Eur J Endocrinol (2010) 0.89
Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother (2010) 0.87
Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece. Med Sci Monit (2008) 0.87
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline. Curr Drug Metab (2009) 0.86
When to include polymyxins in the empirical antibiotic regimen in critically ill patients with fever? A decision analysis approach. Shock (2007) 0.85
Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis. Antimicrob Agents Chemother (2012) 0.85
Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases. J Antimicrob Chemother (2012) 0.83
Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol (2008) 0.83
Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies. J Pediatr (2009) 0.82
Seasonality of mortality: the September phenomenon in Mediterranean countries. CMAJ (2009) 0.82
continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis. PLoS One (2013) 0.81
Susceptibility of Gram-negative bacteria to isepamicin: a systematic review. Expert Rev Anti Infect Ther (2012) 0.81
Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin. Int J Antimicrob Agents (2010) 0.81
Severe Plasmodium vivax malaria complicated with acute respiratory distress syndrome: a case associated with focal autochthonous transmission in Greece. Vector Borne Zoonotic Dis (2014) 0.81
How well do clinical researchers understand risk estimates? Epidemiology (2009) 0.79
Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study. Expert Opin Investig Drugs (2013) 0.79
Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. Pediatr Pulmonol (2010) 0.79
Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis. Expert Rev Anti Infect Ther (2013) 0.78
In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece. Antimicrob Agents Chemother (2012) 0.78
Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease. Exp Diabetes Res (2011) 0.77
Frequency of the off-label use of monoclonal antibodies in clinical practice: a systematic review of the literature. Curr Med Res Opin (2013) 0.76
Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences. Clin Infect Dis (2010) 0.76
Surveillance of community outbreaks of respiratory tract infections based on house-call visits in the metropolitan area of Athens, Greece. PLoS One (2012) 0.76
In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo) (2011) 0.75
Risk factors for isolation of strains susceptible only to polymyxin among patients with Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2006) 0.75
Secular trends of blood isolates in patients from a rural area population hospitalized in a tertiary center in a small city in Greece. BMC Microbiol (2006) 0.75
Clinical Microbiology and Infectious Diseases (ECCMID)--18th European Congress. Drug resistance among Gram-negative and Gram-positive bacteria. IDrugs (2008) 0.75
Severe sepsis and septic shock due to Plasmodium vivax infection. Am J Emerg Med (2013) 0.75
Red streaks on the leg. Lymphangitis. Am Fam Physician (2006) 0.75
A prospective observational study of chronic prostatitis with emphasis on epidemiological and microbiological features. Urologia (2013) 0.75
Limitations in the management of aortic graft infections. Ann Vasc Surg (2006) 0.75
Matching criteria in case-control studies in the field of antimicrobial resistance. Microb Drug Resist (2008) 0.75
Trends of tuberculin skin test positivity rate among schoolchildren in Attica, Greece. Scand J Infect Dis (2009) 0.75
Comparison of adverse events between oral and intravenous formulations of antimicrobial agents: a systematic review of the evidence from randomized trials. Pharmacoepidemiol Drug Saf (2009) 0.75
Probiotics for the prevention of ventilator-associated pneumonia. Expert Rev Respir Med (2010) 0.75
Tooth and consequences. Am J Med (2008) 0.75
Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. Int J Antimicrob Agents (2011) 0.75